Advertisement
Screener

Twist Bioscience Corporation (TWST) Cash Flow Breakdown

Twist Bioscience Corporation Cash Flow Breakdown

Cash flow breakdown shows where Twist Bioscience Corporation's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-09-30: from running the business, $47.63M went out.
  • Fiscal year ended 2025-09-30: from investing, $24.76M went out.
  • Fiscal year ended 2025-09-30: from financing, $28.54M came in.
  • Fiscal year ended 2025-09-30: change in cash, $43.71M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2025-09-30-$47.63M-$24.76M$28.54M*-$43.71M
2024-09-30-$64.09M-$3.07M$0.00$6.89M*-$60.15M
2023-09-30-$142.47M$50.61M$0.00$911.00K*-$90.98M
2022-09-30-$124.39M-$232.93M-$1.56M$272.09M*-$87.10M
2021-09-30-$112.24M$156.16M-$3.33M$332.51M*$373.11M
2020-09-30-$142.25M-$114.65M-$3.33M$3.43M$303.64M*$46.85M
2019-09-30-$87.94M-$104.81M-$2.50M$2.70M$158.38M*-$34.14M
2018-09-30-$66.16M$27.31M$88.82M*$49.96M
2017-09-30-$51.30M-$9.99M-$4.17M$2.17M$65.80M*$2.51M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2026-06-30$1.11M*-$10.20M*$3.79M*
2026-03-31-$17.56M*-$12.71M*$4.14M*
2025-12-31-$24.81M-$9.93M-$34.44M
2025-09-30-$11.81M*-$12.40M*$5.57M*
2025-06-30-$1.40M*-$9.40M*$1.83M*
2025-03-31-$12.99M*-$1.43M*$3.20M*
2024-12-31-$21.43M-$1.54M$17.94M*-$5.07M
2024-09-30-$15.32M*-$1.28M*$3.63M*
2024-06-30-$6.38M*-$711.00K*$2.91M*
2024-03-31-$19.42M*-$5.24M*$1.83M*
2023-12-31-$22.97M$4.17M-$1.47M*-$20.16M
2023-09-30-$20.70M*-$2.25M*$0.00*
2023-06-30-$23.41M*$18.67M*-$661.00K*
2023-03-31-$44.29M*$41.16M*$1.52M*
2022-12-31-$54.07M-$6.97M-$61.17M
2022-09-30-$1.27M*$2.78M*$0.00*$1.24M*
2022-06-30-$34.13M*$4.16M*$0.00*-$1.31M*
2022-03-31-$42.34M*-$13.29M*$271.62M*
2021-12-31-$46.65M-$226.58M-$1.01M*-$274.16M
2021-09-30-$34.80M*$23.91M*-$833.00K*$2.41M*
2021-06-30-$27.96M*$104.58M*-$833.00K*
2021-03-31-$24.55M*$73.59M*-$834.00K*$2.29M*
2020-12-31-$24.93M-$45.92M$326.92M*$256.07M
2020-09-30-$25.20M*-$94.67M*-$833.00K*$1.91M*$4.50M*
2020-06-30-$23.47M*-$61.15M*-$833.00K*$0.00*$108.90M*
2020-03-31-$58.67M*$28.76M*-$834.00K*$188.87M*
2019-12-31-$34.91M$12.40M-$833.00K$2.89M*-$20.44M
2019-09-30-$23.36M*-$1.19M*-$833.00K*$3.76M*
2019-06-30-$22.08M*-$22.71M*-$834.00K*$85.12M*
2019-03-31-$20.81M*-$15.16M*-$1.63M*
2018-12-31-$21.68M-$65.76M$73.00M*-$14.44M
2018-09-30-$16.70M*$404.00K*$6.58M*
2018-06-30-$16.94M*$4.58M*$24.83M*
2018-03-31-$16.51M*$14.11M*$54.75M*
2017-12-31-$16.02M$8.21M$2.66M*-$5.14M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78